Almuth F. Kessler Department of Neurosurgery University Hospital Würzburg Biography Publications Institution JoVE Articles Almuth F. Kessler has not added a biography. If you are Almuth F. Kessler and would like to personalize this page please email our Author Liaison for assistance. Publications Characterization and Optimization of the Tumor Microenvironment in Patient-Derived Organotypic Slices and Organoid Models of Glioblastoma Cancers. May, 2023 | Pubmed ID: 37345035 Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier Pharmaceutics. Jan, 2023 | Pubmed ID: 36678814 The Emesis Trial: Depressive Glioma Patients Are More Affected by Chemotherapy-Induced Nausea and Vomiting Frontiers in Neurology. 2022 | Pubmed ID: 35242096 Glioma Patients in Outpatient Care-optimization of Psychosocial Care in Neuro-oncological Patients (GLIOPT): Protocol for a Cluster Randomized Controlled Trial Trials. May, 2020 | Pubmed ID: 32460811 ADAM9: A Novel Player in Vestibular Schwannoma Pathogenesis Oncology Letters. Mar, 2020 | Pubmed ID: 32194680 Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PET Clinical Nuclear Medicine. Sep, 2019 | Pubmed ID: 31274552 [Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular Schwannomas Frontiers in Oncology. 2019 | Pubmed ID: 31245296 Cytotoxic T Cells and Their Activation Status Are Independent Prognostic Markers in Meningiomas Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2019 | Pubmed ID: 31227506 Circulating MACC1 Transcripts in Glioblastoma Patients Predict Prognosis and Treatment Response Cancers. Jun, 2019 | Pubmed ID: 31200581 Identification of KIF11 As a Novel Target in Meningioma Cancers. Apr, 2019 | Pubmed ID: 30991738 Prognostic Value of O-(2-[F]Fluoroethyl)-L-Tyrosine PET/CT in Newly Diagnosed WHO 2016 Grade II and III Glioma Molecular Imaging and Biology. Dec, 2019 | Pubmed ID: 30977078 O-(2-(F)fluoroethyl)-L-tyrosine PET for the Differentiation of Tumour Recurrence from Late Pseudoprogression in Glioblastoma Journal of Neurology, Neurosurgery, and Psychiatry. Feb, 2019 | Pubmed ID: 29705720 CXCR4: A New Player in Vestibular Schwannoma Pathogenesis Oncotarget. Feb, 2018 | Pubmed ID: 29515781 Screening for Symptom Burden and Supportive Needs of Patients with Glioblastoma and Brain Metastases and Their Caregivers in Relation to Their Use of Specialized Palliative Care Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. Sep, 2017 | Pubmed ID: 28357650 Feasibility of the Combined Application of Navigated Probabilistic Fiber Tracking and Navigated Ultrasonography in Brain Tumor Surgery World Neurosurgery. Jun, 2016 | Pubmed ID: 26968447 (68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma Theranostics. 2016 | Pubmed ID: 26909116 TERT Promoter Mutations and Risk of Recurrence in Meningioma Journal of the National Cancer Institute. May, 2016 | Pubmed ID: 26668184 Comparison of the Amino Acid Tracers 18F-FET and 18F-DOPA in High-grade Glioma Patients Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Oct, 2014 | Pubmed ID: 25125481 Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma Marah Alsalkini1, Veronika Cibulková1, Maria Breun2, Almuth F. Kessler2, Tim Schulz2, Andrea Cattaneo2, Christoph Wipplinger2, Julian Hübner3, Ralf-Ingo Ernestus2, Thomas Nerreter3, Camelia M. Monoranu4, Carsten Hagemann1, Mario Löhr2, Vera Nickl2 1Section Experimental Neurosurgery, Department of Neurosurgery, University Hospital Würzburg, 2Department of Neurosurgery, University Hospital Würzburg, 3Department of Hematology, University Hospital Würzburg, 4Department of Neuropathology, Institute of Pathology, University Hospital Würzburg JoVE 65952 Investigación sobre el cáncer
Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma Marah Alsalkini1, Veronika Cibulková1, Maria Breun2, Almuth F. Kessler2, Tim Schulz2, Andrea Cattaneo2, Christoph Wipplinger2, Julian Hübner3, Ralf-Ingo Ernestus2, Thomas Nerreter3, Camelia M. Monoranu4, Carsten Hagemann1, Mario Löhr2, Vera Nickl2 1Section Experimental Neurosurgery, Department of Neurosurgery, University Hospital Würzburg, 2Department of Neurosurgery, University Hospital Würzburg, 3Department of Hematology, University Hospital Würzburg, 4Department of Neuropathology, Institute of Pathology, University Hospital Würzburg JoVE 65952 Investigación sobre el cáncer
